Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Spring Sale
Enjoy this offer
* See conditions under "Our services"

Valuation: Lonza Group AG

Capitalization 34.87B 44.7B 38.62B 33.35B 60.78B 4,122B 62.49B 412B 164B 1,971B 168B 164B 7,099B P/E ratio 2025
39.8x
P/E ratio 2026 * 30.2x
Enterprise value 38.33B 49.14B 42.46B 36.66B 66.82B 4,531B 68.7B 453B 181B 2,167B 184B 180B 7,804B EV / Sales 2025
6.28x
EV / Sales 2026 * 5.34x
Free-Float
93.86%
Yield 2025
0.93%
Yield 2026 * 1.09%

Last Transcript: Lonza Group AG

1 day-2.27%
1 week-6.85%
Current month-8.69%
1 month-3.39%
3 months-6.60%
6 months-12.32%
Current year-8.96%
1 week 485.8
Extreme 485.8
526.4
1 month 485.8
Extreme 485.8
542.4
Current year 485.8
Extreme 485.8
585.6
1 year 467.8
Extreme 467.8
605.2
3 years 308.6
Extreme 308.6
616
5 years 308.6
Extreme 308.6
785.4
10 years 152.8
Extreme 152.8
785.4
Manager TitleAgeSince
Chief Executive Officer 54 01/07/2024
Director of Finance/CFO 54 01/12/2021
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 65 16/04/2014
Director/Board Member 68 16/04/2014
Director/Board Member 66 26/04/2016
Change 5d. change 1-year change 3-years change Capi.($)
-1.39%-6.85%-8.31%-6.92% 44.92B
-2.21%+0.32%+22.09%+34.99% 33.88B
+1.46%-7.11%+18.65%+47.53% 30.76B
+0.38%-3.26%-6.21%-13.14% 28.69B
+0.95%-1.63%+155.95%+340.83% 19.59B
-5.53%-5.03%+57.41%+112.95% 14.76B
+2.17%+2.20%+46.11%+173.15% 13.25B
-0.75%-5.48%+25.26%+0.16% 13.06B
-2.63%-6.60%+22,303.39%+3,308.37% 12.12B
-1.14%-5.64%+126.98%+123.26% 12.5B
Average -0.92%-1.04%+2,274.13%+412.12% 22.35B
Weighted average by Cap. -0.91%-1.20%+1,241.48%+242.64%

Financials

2025 2026 *
Net sales 7.57B 9.7B 8.38B 7.24B 13.19B 894B 13.56B 89.45B 35.65B 428B 36.39B 35.63B 1,541B 7.14B 9.15B 7.91B 6.83B 12.45B 844B 12.8B 84.39B 33.64B 404B 34.34B 33.61B 1,453B
Net income 1.03B 1.32B 1.14B 982M 1.79B 121B 1.84B 12.13B 4.84B 58.02B 4.94B 4.83B 209B 1.17B 1.5B 1.3B 1.12B 2.04B 138B 2.1B 13.84B 5.52B 66.18B 5.63B 5.51B 238B
Net Debt 3.46B 4.44B 3.84B 3.31B 6.04B 409B 6.21B 40.94B 16.32B 196B 16.66B 16.31B 705B 3.23B 4.15B 3.58B 3.09B 5.64B 382B 5.8B 38.23B 15.24B 183B 15.55B 15.23B 658B
Logo Lonza Group AG
Lonza Group AG is one of the world leaders of the contract development and manufacturing of pharmaceutical and biotechnology products. Net sales break down by family of products and services as follows: - biologics and bio-pharmaceuticals (55.9%): microbiological fermentation products, mammalian cell-based bio-pharmaceuticals, monoclonal antibodies, therapeutic proteins, etc.; - synthesis products (24.7%): chemopharmaceutical products, bioconjugates, small molecules, active pharmaceutical ingredients, complex intermediates, etc.; - specialised therapeutic products (15.8%): cell and gene therapies, synthetic therapeutic nucleic acids, oligonucleotides, microbial biological products, etc.; - others (3.6%).
Employees
19,771
Date Price Change Volume
11/03/26 489.60 CHF -1.39% 201,508
10/03/26 496.50 CHF -0.44% 127,275
09/03/26 498.70 CHF -1.09% 193,292
06/03/26 504.20 CHF -2.02% 161,134
05/03/26 514.60 CHF -2.09% 131,092
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
496.50CHF
Average target price
675.78CHF
Spread / Average Target
+36.11%

Quarterly revenue - Rate of surprise

SPRING SALE -40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW